207 related articles for article (PubMed ID: 23993706)
1. Phenotypic predictors of response to oral glucocorticosteroids in severe asthma.
Kupczyk M; Haque S; Middelveld RJ; Dahlén B; Dahlén SE;
Respir Med; 2013 Oct; 107(10):1521-30. PubMed ID: 23993706
[TBL] [Abstract][Full Text] [Related]
2. Predictors for identifying the efficacy of systemic steroids on sustained exhaled nitric oxide elevation in severe asthma.
Matsunaga K; Hirano T; Akamatsu K; Minakata Y
Allergol Int; 2013 Sep; 62(3):359-65. PubMed ID: 23880612
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of phenotypes in severe asthmatics. The Belgian Severe Asthma Registry (BSAR).
Schleich F; Brusselle G; Louis R; Vandenplas O; Michils A; Pilette C; Peche R; Manise M; Joos G
Respir Med; 2014 Dec; 108(12):1723-32. PubMed ID: 25456708
[TBL] [Abstract][Full Text] [Related]
4. A sputum gene expression signature predicts oral corticosteroid response in asthma.
Berthon BS; Gibson PG; Wood LG; MacDonald-Wicks LK; Baines KJ
Eur Respir J; 2017 Jun; 49(6):. PubMed ID: 28663317
[TBL] [Abstract][Full Text] [Related]
5. Frequent exacerbators--a distinct phenotype of severe asthma.
Kupczyk M; ten Brinke A; Sterk PJ; Bel EH; Papi A; Chanez P; Nizankowska-Mogilnicka E; Gjomarkaj M; Gaga M; Brusselle G; Dahlén B; Dahlén SE;
Clin Exp Allergy; 2014 Feb; 44(2):212-21. PubMed ID: 24447083
[TBL] [Abstract][Full Text] [Related]
6. Stability of phenotypes defined by physiological variables and biomarkers in adults with asthma.
Kupczyk M; Dahlén B; Sterk PJ; Nizankowska-Mogilnicka E; Papi A; Bel EH; Chanez P; Howarth PH; Holgate ST; Brusselle G; Siafakas NM; Gjomarkaj M; Dahlén SE;
Allergy; 2014 Sep; 69(9):1198-204. PubMed ID: 25039610
[TBL] [Abstract][Full Text] [Related]
7. Comparison of a short course of prednisolone with sustained-release theophylline in the control of nocturnal asthma.
Chhabra SK
Indian J Chest Dis Allied Sci; 1995; 37(1):7-14. PubMed ID: 16892732
[TBL] [Abstract][Full Text] [Related]
8. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia.
Nair P; Pizzichini MM; Kjarsgaard M; Inman MD; Efthimiadis A; Pizzichini E; Hargreave FE; O'Byrne PM
N Engl J Med; 2009 Mar; 360(10):985-93. PubMed ID: 19264687
[TBL] [Abstract][Full Text] [Related]
9. Effects of prednisolone on eosinophils, IL-5, eosinophil cationic protein, EG2+ eosinophils, and nitric oxide metabolites in the sputum of patients with exacerbated asthma.
Jang AS; Choi IS; Koh YI; Jeong TK; Lee KY; Kim YS; Lee JU; Park CS
J Korean Med Sci; 2000 Oct; 15(5):521-8. PubMed ID: 11068988
[TBL] [Abstract][Full Text] [Related]
10. Increased levels of airway neutrophils reduce the inhibitory effects of inhaled glucocorticosteroids on allergen-induced airway eosinophils.
Gauvreau GM; Inman MD; Kelly M; Watson RM; Dorman SC; O'Byrne PM
Can Respir J; 2002; 9(1):26-32. PubMed ID: 11856987
[TBL] [Abstract][Full Text] [Related]
11. The effects of oral corticosteroids on lung function, type-2 biomarkers and patient-reported outcomes in stable asthma: A systematic review and meta-analysis.
Busby J; Khoo E; Pfeffer PE; Mansur AH; Heaney LG
Respir Med; 2020 Nov; 173():106156. PubMed ID: 32979621
[TBL] [Abstract][Full Text] [Related]
12. Prednisolone oral solution plus inhaled procaterol for acute asthma in children: a double-blind randomized controlled trial.
Huang LH; Shyur SD; Wen DC; Chang YC; Ma YC; Lin SC; Wu WC; Wu JY
Acta Paediatr Taiwan; 2007; 48(5):257-62. PubMed ID: 18254574
[TBL] [Abstract][Full Text] [Related]
13. Responsiveness to oral prednisolone in severe asthma is related to the degree of eosinophilic airway inflammation.
Sousa AR; Marshall RP; Warnock LC; Bolton S; Hastie A; Symon F; Hargadon B; Marshall H; Richardson M; Brightling CE; Haldar P; Milone R; Chalk P; Williamson R; Panettieri R; Knowles R; Bleecker ER; Wardlaw AJ
Clin Exp Allergy; 2017 Jul; 47(7):890-899. PubMed ID: 28493293
[TBL] [Abstract][Full Text] [Related]
14. [Relation between clinical severity of bronchial asthma and degree of airway inflammation assessed by the eosinophilic leukocyte count in induced sputum].
Chlumský J; Pokorná H
Vnitr Lek; 2001 Sep; 47(9):604-8. PubMed ID: 11715664
[TBL] [Abstract][Full Text] [Related]
15. [Control of asthma symptoms and cellular markers of inflammation in induced sputum in children and adolescents with chronic asthma].
Ciółkowski J; Stasiowska B; Mazurek H
Pol Merkur Lekarski; 2009 Mar; 26(153):178-83. PubMed ID: 19388528
[TBL] [Abstract][Full Text] [Related]
16. Effects of steroid therapy on inflammatory cell subtypes in asthma.
Cowan DC; Cowan JO; Palmay R; Williamson A; Taylor DR
Thorax; 2010 May; 65(5):384-90. PubMed ID: 19996343
[TBL] [Abstract][Full Text] [Related]
17. Predicting steroid responsiveness in patients with asthma using exhaled breath profiling.
van der Schee MP; Palmay R; Cowan JO; Taylor DR
Clin Exp Allergy; 2013 Nov; 43(11):1217-25. PubMed ID: 24152154
[TBL] [Abstract][Full Text] [Related]
18. Importance of concomitant local and systemic eosinophilia in uncontrolled asthma.
Schleich FN; Chevremont A; Paulus V; Henket M; Manise M; Seidel L; Louis R
Eur Respir J; 2014 Jul; 44(1):97-108. PubMed ID: 24525441
[TBL] [Abstract][Full Text] [Related]
19. Increase in airway neutrophils after oral but not inhaled corticosteroid therapy in mild asthma.
Nguyen LT; Lim S; Oates T; Chung KF
Respir Med; 2005 Feb; 99(2):200-7. PubMed ID: 15715187
[TBL] [Abstract][Full Text] [Related]
20. The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma.
Beeh KM; Kanniess F; Wagner F; Schilder C; Naudts I; Hammann-Haenni A; Willers J; Stocker H; Mueller P; Bachmann MF; Renner WA
J Allergy Clin Immunol; 2013 Mar; 131(3):866-74. PubMed ID: 23384679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
